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ELAINE DRAPER, RISKY BUSINESS: GENETIC TESTING AND
EXCLUSIONARY PRACTICES IN THE HAZARDOUS WORK-
PLACE. (Cambridge University Press 1991) [315 pp.] Index of names and
subjects, glossary, notes, references. LC 90-28112; ISBN 0-521-37027-2 (cloth
$49.50); ISBN 0-42248-5 (paper $15.95). [40 W. 20th St., New York NY 10011.]
There are at least two divergent accounts of the nature and
consequences of workplace exposure to hazardous substances.
According to one view, the risks created by exposure to certain
chemicals represent threats to everyone and, therefore, they ought to be
reduced as much as possible. On this account, emission of certain
chemicals is a social disease causing ubiquitous harm.
According to a second view, workplace exposure to certain
substances represents a threat only to particular persons. Hence, in
order to protect them, susceptible individuals ought to be removed from
occupations involving such exposures. On this second view, exposure
to chemicals is not generally harmful, since only hypersensitive
individuals are affected.
Proponents of the first view tend to blame industry for general
chemical hazards to workers and the public. Proponents of the second
view, however, tend to blame susceptible workers, particular
individuals who are the most obvious victims of chemical exposures.
The main purpose of RISKY BUSINESS is to argue against the second
view and therefore against the practice of genetic screening to determine
worker susceptibility. Instead, sociologist Elaine Draper argues for
stricter health standards for chemical exposures. Like canaries used by
coal miners for early detection of methane, Draper claims that genetically
susceptible members of high-risk groups also provide warning signals
for conditions likely to be dangerous for all workers. If employers react
to the warnings by removing the canaries, the high-risk workers,
instead of reducing hazardous workplace exposures, Draper argues that
deadly consequences will follow for everyone. Less susceptible
workers will lose their signals that warned of danger, and exposures
and health hazards will increase, ultimately harming even more persons.
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Using case studies of two large chemical companies, Dow and
DuPont, Draper chronicles how contemporary industries are removing
the canaries, the high-risk workers. They also deliberately fail to inform
more susceptible employees of possible hazards, deny the risks
involved and therefore accelerate the threat to other workers. More
importantly, Draper reveals how industry paints a deadly,
occupationally induced hazard as a problem of unique, individual
susceptibility. Using 120 interviews, as well as documentary materials
and workplace observations, Draper provides an account that is sure to
become a classic in the risk literature.
RISKY BUSINESS includes seven chapters as well as 100 pages of
references and notes. The first chapter outlines the emergence of genetic
testing and susceptibility explanations, surveying the conflict between
labor and management over how to define workers at risk from
hazardous chemicals. 1 Chapter 2 explains the way that industry often
defines and debates workplace risk, in terms of specific, genetic
propensities of individuals, rather than as a societal threat to virtually
everyone. In other words, industry typically deals with workplace risk
by "blaming the victim"2 and by projecting social ills onto individuals 3
whom industry then defines as unusual or atypical. 4 Chapter 3 shows
how managers and scientists who accept the individual-susceptibility
approach make it appear that all workers and exposure conditions not
considered "high risk" are safe.5 In Chapter 4, Draper analyzes the
stratification of the work force. She argues that, contrary to its
proponents, the new genetic screening technology is neither ethically
nor politically neutral. Instead the process often singles out women and
minorities. 6 Hence, she argues, the search for workers most at risk








Chapter 5 surveys the use of genetic susceptibility tests, showing
that the results are typically denied to workers, even after they ask,7 and
that the tests are rarely used to monitor and improve worker health.
Instead, the chapter argues that the results are used largely to "remove
the canary" and to deny that any health threat exists. Such denial is
possible, Draper argues, because workers in dangerous industries
typically are not unionized. 8 Chapter 6 uncovers the legal and regulatory
environment that is conducive to removing particular employees, rather
than to reducing workplace exposures to hazardous substances. Such an
environment encourages initial screening, not continual surveillance -
and secrecy, not honesty, about hazards.9 Hence, Draper argues that
there is virtually no sense in which genetic screening has helped
workers in any way. In Chapter 7, Draper summarizes the arguments
and suggests the policy implications of her findings. With the rapid
growth of genetic knowledge and the increasing influence of economic,
legal and regulatory factors, Draper predicts that exclusionary testing
will become even more prevalent in the future.
Draper's book deserves high praise, not only because of the wealth
of information about chemical risks, genetics, occupational medicine
and corporate policies and politics that it includes, but also because of
her compelling sociological thesis. This thesis is that industry
assimilates scientific and technological developments - like genetic
testing - in ways that both reflect and serve its social biases and power
relationships. Because her volume attempts to tell a story of causes and
motives, and not merely actions and consequences, Draper is likely to
be both praised for her insights but attacked by those who are
uncomfortable with her case-study methodology. The complex
inferences associated with the sociology of risk are typically not
amenable to the precise and quantitative techniques of hypothesis
deduction often used in other sciences. Because they are not, some
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case with a variety of statistical methods and tests.
In response, however, Draper's defenders should point out that, in
order to deal with some of issues she confronts, Draper could have used
only informal methods such as interviews, observations and analysis of
documents. Also, one book cannot do everything, and Draper's volume
is meant to achieve sociological analysis, not statistical proof. In laying
a plausible sociological foundation for a compellingly correct thesis,
Draper accomplishes more than most authors. She shows us how
industry apparently uses advances in science and technology to serve its
own economic ends and social biases.
In laying a sociological foundation for future work on occupational
risks and genetic screening, Draper has achieved a number of goals that
make her work unique and particularly noteworthy. For one thing, the
type of sociological analysis that she uses has never before been brought
to bear on the question of exclusionary testing of workers in the
chemical industry. Second, Draper consistently employs a detailed,
analytic treatment of alternative positions on particular issues related to
genetic testing in the workplace. She carefully exposes the assumptions
and traces the consequences of opposing arguments, revealing logical
and social analysis at its best. Third, Draper does a superb job of
showing how the shift from emphasis on chemical hazards to emphasis
on individual susceptibility is neither a scientific breakthrough nor an
objective analysis of recent consequences of genetic developments.
Rather, she reveals that the shift is a socially constructed account
designed to serve special interests. Fourth, Draper serves policymakers
well by outlining specific alternatives to exclusionary genetic testing in
the workplace. For all these reasons, her volume is a landmark
discussion of the sociological study of workplace risk.
Kristin S. Shrader-Frechette t
t See previous review.
